Evidence map›Paper›PMID 30944967›Full record

ReviewWorld journal of urology2020

Metagenomics in diagnosis and improved targeted treatment of UTI.

Matthew Dixon, Maria Stefil, Michael McDonald, Truls Erik Bjerklund-Johansen, Kurt Naber, Florian Wagenlehner, Vladimir Mouraviev

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in World journal of urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Emerging priorities for microbial metagenome research.Bioresource technology reports · 2020
    Review
  18. Urogenital infections.World journal of urology · 2020
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Matthew DixonNorwich Medical School, University of East Anglia, Norwich, UK.
Maria StefilNorwich Medical School, University of East Anglia, Norwich, UK.
Michael McDonaldFlorida Hospital Celebration Health, Celebration, FL, USA.
Truls Erik Bjerklund-JohansenDepartment of Urology, Oslo University Hospital, Oslo, Norway.
Kurt NaberDepartment of Urology, Technical University of Munich, Munich, Germany.
Florian WagenlehnerDepartment of Urology, Pediatric Urology and Andrology, Justus-Liebig University, Giessen, Germany.
Vladimir MouravievFlorida Hospital Celebration Health, Celebration, FL, USA. mouraviev@cfcancerinst.com.ORCID http://orcid.org/0000-0003-2752-8422
University of Central Florida · USUniversity of East Anglia · GBJustus-Liebig-Universität Gießen · DEOslo University Hospital · NOTechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe genomic revolution has transformed our understanding of urinary tract infection. There has been a paradigm shift from the dogmatic statement that urine is sterile in healthy people, as we are becoming forever more familiar with the knowledge that bacterial communities exist within the urinary tracts of healthy people. Metagenomics can investigate the broad populations of microbial communities, analysing all the DNA present within a sample, providing comprehensive data regarding the state of the microenvironment of a patient's urinary tract. This permits medical practitioners to more accurately target organisms that may be responsible for disease-a form of 'precision medicine'. METHODS AND

resultsThis paper is derived from an extensive review and analysis of the available literature on the topic of metagenomic sequencing in urological science, using the PubMed search engine. The search yielded a total of 406 results, and manual selection of appropriate papers was subsequently performed. Only one randomised clinical trial comparing metagenomic sequencing to standard culture and sensitivity in the arena of urinary tract infection was found.

conclusionOut of this process, this paper explores the limitations of traditional methods of culture and sensitivity and delves into the recent studies involving new high-throughput genomic technologies in urological basic and clinical research, demonstrating the advances made in the urinary microbiome in its entire spectrum of pathogens and the first attempts of clinical implementation in several areas of urology. Finally, this paper discusses the challenges that must be overcome for such technology to become widely used in clinical practice.

Indexed as

BacteriaDNA, BacterialHumansMetagenomicsUrinary Tract InfectionsDNA, BacterialInfectious urologyMetagenomicsNext-generation sequencingPrecision medicineTargeted treatmentUrinary tract infection

Identifiers

PMID30944967
OpenAlexW2931176934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.